# A Drug-Drug Interaction Study of Ambroxol and Levodropropizine

> **NCT01573663** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 21 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Ambroxol and Levodropropizine
- **DRUG:** Ambroxol
- **DRUG:** Levodropropizine

## Key facts

- **NCT ID:** NCT01573663
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2012-04
- **Final completion:** 2012-04
- **Target enrollment:** 21 (ACTUAL)
- **Last updated:** 2012-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01573663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01573663, "A Drug-Drug Interaction Study of Ambroxol and Levodropropizine". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01573663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*